Intragastric Balloons Market Trends That Will Shape the Next Decade: Insights from Advancements In Non-Surgical Weight Loss Solutions

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Intragastric Balloons Market Size By 2025?
The market size of intragastric balloons has seen significant growth lately. It is projected to rise from a value of $19.89 billion in 2024 to $22.05 billion in 2025, with a compound annual growth rate (CAGR) of 10.9%. The expansion witnessed in the historical phase can be credited to rising obesity levels, increased expenditure on healthcare, approvals from the FDA substantiated by clinical proofs, awareness initiatives, enhanced designs of balloons, and a boom in medical tourism.

How Big Is the Intragastric Balloons Market Size Expected to Grow by 2029?
The market for intragastric balloons is anticipated to witness a significant surge in the upcoming years, eventually growing to a valuation of $33.15 billion by 2029, expanding at a compound annual growth rate (CAGR) of 10.7%. This projected growth within the forecast period can be traced back to factors such as celebrity endorsements, health complications related to obesity, expansion in nascent markets, a rising number of endoscopic procedures, an elderly population, and the introduction of personalized treatments. The forecast period is also expected to showcase notable trends including technological advancements, widespread awareness through social media platforms, incorporation with digital health infrastructures, use of artificial intelligence, the adoption of virtual consultations, and a focus on enhanced educational initiatives for patients.

View the full report here:
https://www.thebusinessresearchcompany.com/report/intragastric-balloons-global-market-report

Which Key Market Drivers Powering Intragastric Balloons Market Expansion and Growth?
The rise in obesity rates is anticipated to fuel the advancement of the intragastric balloon market. Here, obesity rates are defined as the proportion of a population identified as obese based on body mass index (BMI) readings, usually described as a BMI of 30 or over. The increment in obesity rates stems from dietary routines, sedentary lifestyles, economic factors, advertorial and marketing techniques, genetic and biological factors, psychological factors, and changes in urbanization and infrastructure. Obese people often choose intragastric balloons as a non-invasive method for weight loss as it occupies space in the stomach leading to the sensation of fullness and lesser food consumption. As per the World Obesity Atlas 2022 published in March 2023 by the World Obesity Federation, a UK non-profit organization, it is projected that the global economic impact of excess weight and obesity could hit $4.32 trillion per year by 2035 if current preventive and treatment methods do not evolve. By then, around half of the world population (51%, or over 4 billion people) might be struggling with overweight or obesity problems, with almost 2 billion individuals or 1 out of 4 individuals predicted to be obese if current trends persist. Therefore, the surge in obesity rates fuels the expansion of the intragastric balloon market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15835&type=smp

What Long-Term Trends Will Define the Future of the Intragastric Balloons Market?
Leading firms in the intragastric balloon market are prioritizing the production of advanced medical devices for weight loss, such as ingetable gastric balloons that improve patient comfort, ease of application, and availability. Ingestable gastric balloons, which are non-invasive devices, contribute to weight loss by occupying some room in the stomach temporarily, creating a sense of satiety and limiting food intake. For example, Allurion Technologies Inc., a medical device company based in the United States, released an ingestible gastric balloon capsule in India in September 2022. This is the first-ever ingestable gastric balloon in the world that does not necessitate endoscopy or anesthesia for insertion or extraction. The Allurion gastric balloon capsule provides individuals with a safe, non-invasive, and effective solution for weight loss, enabling them to achieve substantial weight reduction and cultivate healthier lifestyle habits for enduring success.

What Are the Emerging Segments in the Intragastric Balloons Market?
The intragastric balloons market covered in this report is segmented -

1) By Type: Single, Dual, Triple Intragastric Balloons
2) By Filling Material: Saline Filled, Gas Filled
3) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies
4) By Application Areas: Obesity, Diabetes, Diet Control, Weight-loss, Pre-operative Weight Reduction, Other Applications
5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:
1) By Single Intragastric Balloon: Silicone-Based Single Balloon, Non-silicone-Based Single Balloon
2) By Dual Intragastric Balloon: Silicone-Based Dual Balloon, Non-silicone-Based Dual Balloon
3) By Triple Intragastric Balloon: Silicone-Based Triple Balloon, Non-silicone-Based Triple Balloon

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15835&type=smp

Who Are the Global Leaders in the Intragastric Balloons Market?
Major companies operating in the intragastric balloons market are Medtronic plc, Mayo Clinic, Boston Scientific Corporation, Cleveland Clinic, Mediclinic Group, Spire Healthcare Group plc, Micro-Tech (Nanjing) Co., Ltd., American Hospital Dubai LLC, Silimed GmbH, Apollo Endosurgery Inc., Allurion Technologies Inc., MedicalExpo, ReShape Lifesciences Inc., Districlass Medical SA, Healthware Private Limited, Spatz Medical, Helioscopie SA, Bariatric Solutions International GmbH, HexaHealth Care Pvt. Ltd., USGI Medical Inc., Inamed Health, Medsil, Obalon Therapeutics Inc., Endalis, Lexel SRL

Which are the Top Profitable Regional Markets for the Intragastric Balloons Industry?
North America was the largest region in the intragastric balloons market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intragastric balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15835

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.